Scientific Publications
Scientific Publications
Roflumilast Cream, Safety and Efficacy in two Ph3 Studies (DERMIS-1 and DERMIS-2) in Patients with Chronic Plaque Psoriasis – EADV Spring Symposium 2021 – May 2021
Roflumilast Foam, Safety and Efficacy in Patients with Seborrheic Dermatitis, Ph2 Study – AAD 2021 – April 2021
Roflumilast Foam, Safety and Efficacy in Patients with Scalp and Body Psoriasis, Ph2b Study – AAD 2021 – April 2021
Roflumilast Cream, Correlation of Itch and Disease Severity in Adults with Chronic Plaque Psoriasis, Ph2b Study – AAD 2021 – April 2021
Roflumilast Cream, Safety and Efficacy in Steroid-sensitive Areas in Adults with Chronic Plaque Psoriasis, Ph2b Study – AAD 2021 – April 2021
PASI-HD Improved Precision in Measuring Disease Severity in Patients with Mild to Moderate Plaque Psoriasis Treated with Roflumilast Cream, Ph2b Study – AAD 2021 – April 2021
Roflumilast Cream, Long-term Safety and Efficacy in a Ph2b Study in Adults with Chronic Plaque Psoriasis – Innovations in Dermatology 2021 – March 2021
Roflumilast Cream, Safety and Efficacy in a Ph2 Proof-of-Concept study in Adults with Atopic Dermatitis – EADV, Fall Clinical, SDPA 2020 – October 2020 – Innovations in Dermatology 2021 – March 2021
Roflumilast Cream, Improved Itch Severity and Itch-related Sleep Loss in Adults with Chronic Plaque Psoriasis, Ph2b study – EADV, Fall Clinical, SDPA 2020 – October 2020 – Innovations in Dermatology 2021 – March 2021
Roflumilast Cream, Improved Patient Burden of Signs and Symptoms in Adults with Chronic Plaque Psoriasis, Ph2b study – EADV, Fall Clinical, SDPA 2020 – October 2020 – Innovations in Dermatology 2021 – March 2021
Roflumilast Cream, Results of Phase 1/2a Study – Journal of Drugs in Dermatology – August 2020
Trial of Roflumilast Cream for Chronic Plaque Psoriasis – New England Journal of Medicine – July 2020